EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling

Journal of Applied Physiology

Volumn 108, Issue 6, 2010, Pages 1745-1756

  Ou, Hsiu Churig ^a   Song, Tuzz Ying ^b   Yeh, Yueh Chiao ^c   Huang, Chih Yang ^a,d   Yang, Shun Fa ^e   Chiu, Tsan Hung ^f   Tsai, Kun Ling ^a   Chen, Kai Ling ^a   Wu, Yun Jhen ^a   Tsai, Chiou Sheng ^g   Chang, Li Yun ^h   Kuo, Wei Wen ^a   Lee, Shin Da ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Chungchou Institute of Technology   (China)

^c NANHUA UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h Graduate Institute of Molecular Systems Biomedicine   (Taiwan)

Author keywords

Adhesion molecule; Inflammation; Lectin like oxidized low density lipoprotein receptor 1; Nicotinamide adenine dinucleotide phosphate oxidase; Reactive oxygen; Species

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; CELL CULTURE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; METABOLISM; NEWBORN; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; DRUG EFFECTS;

CATECHIN; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; OXIDATION-REDUCTION; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION;

EID: 77953158972     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00879.2009     Document Type: Article

References (59)

1. Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW. Activation of the NADPH oxidase involves the small GTP-binding protein p21racl. Nature 353: 668-670, 1991.
2. Ahn HY, Xu Y, Davidge ST. Epigallocatechm-3-O-gallate inhibits TNFa-induced monocyte chemotactic protein-1 production from, vascular endothelial cells. Life Sci 82: 964-968, 2008.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Chae YJ, Kim CH, Ha TS, Hescheler J, Ahn HY, Sachinidis A. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion, molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol. Biochem 20: 859-866, 2007.
5. Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, LandisPiwowar KR, Cui QC, Wali A, Chan TH, Dou QP. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 23: 487-496, 2008.
6. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D. Role of caspases in ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94: 370-376, 2004.
7. Chen L, Yu LJ, Waxman DJ. Potentiation of cytochrome P450Acyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene. Cancer Res 57: 4830-4837, 1997.
8. Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoproteininduced apoptosis in human, umbilical vein endothelial cells: role of reactive oxygen species. Vascul. Pharmacol. 47: 1-9, 2007.
9. Chen XP, Zhang TT, Du GH. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc Drug Rev 25: 146-161, 2007.
10. Choi JS, Choi YJ, Shin SY, Li J, Kang SW, Bae JY, Kim DS, Ji GE, Kang JS, Kang YH. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAKASTAT-signaling. J Nutr 138: 983-990, 2008.
11. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Caseio V, Sawamura T. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF- KB through an increased production of intracellular reactive oxygen species. J Biol Chem 275: 12633-12638, 2000.
12. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio V, Sawamura T. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276: 13750-13755, 2001.
13. Cross AR, Jones OT. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237: 111-116, 1986.
14. Dandapat A, Hu C, Sun L, Mehta JL. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1 dependent redox-sensitive pathway. Arterioscler Thromb Vase Biol 27: 24352442, 2007.
15. de Graaf JC, Banga JD, Moneada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion, under now conditions. Circulation 85: 2284-2290, 1992.
16. Tedeschi E, Suzuki H, Menegazz M. Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 Inhibition. Ann NY Acad Sci 973: 435-437, 2002.
17. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185: 219-226, 2006.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
19. Guo Q, Zhao B, Li M, Shen S, Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation, in synaptosomes. Biochim Biophys Acta 1304: 210-222, 1996.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
21. Hu Q, Yu ZX, Ferrans VJ, Takeda K, Irani K, Ziegelstein RC. Critical role of NADPH oxidase-derived reactive oxygen species in generating Ca2+ oscillations in human aortic endothelial cells stimulated by histamine. J Biol Chem 277: 32546-32551, 2002.
22. 2. Free Radic Biol Med 26: 905-918, 1999.
23. Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnard M, Quon MJ. Epigallocatechin gallate, a green, tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282: 13736-13745, 2007.
24. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, Berliner JA. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb 14: 427-433, 1994.
25. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991.
26. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vase Biol 20: 11161122, 2000.
27. Li DY, Chen HJ, Mehta JL. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res 52: 130-135, 2001.
28. Li YM, Chen HY, Huang Y, Chen ZY. Green tea catechins upregulate superoxide dismutase and catalase in fruit flies. Mol Nutr Food Res 51: 546-554, 2007.
29. Lin SJ, Shyue SK, Liu PL, Chen YH, Ku HH, Chen JW, Tarn KB, Chen YL. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogenactivated protein kinase pathways. J Mol Cell Cardiol 36: 129-139, 2004.
30. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction, of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappa B. Mol Pharmacol 52: 465-472, 1997.
31. Ludwig A, Lorenz M, Grimbo N, Steinle F, Meiners S, Bartsch C, Stangl K, Baumann G, Stangl V. The tea flavonoid epigallocatechin-3gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 316: 659-665, 2004.
32. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vase Biol 25: 29-38, 2005.
33. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874, 1993.
34. Matsui T, Yamagishi S, Nakamura K, Inoue H, Takeuchi M. Nifedipine, a calcium-channel blocker, inhibits advanced glycation end-productinduced expression of monocyte chemoattractant protein-1 in human cultured mesangial cells. J Int Med Res 35: 107-112, 2007.
35. Mehta JL, Chen J, Yu F, Li DY. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 64: 243-249, 2004.
36. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 39: 1429-1435, 2002.
37. Meng Q, Velalar CN, Ruan R. Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic Biol Med 44: 1032-1041, 2008.
38. Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T. Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium. Biochem Biophys Res Commun 281: 720-725, 2001.
39. Nakagawa K, Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo) 43: 679-684, 1997.
40. Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 61: 1981-1985, 1997.
41. Navarro-Peran E, Cabezas-Herrera J, Sanchez-Del-Campo L, Garcia-Canovas F, Rodriguez-Lopez JN. The anti-inflammatory and anticancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression, Inflamm Res 57: 472-478, 2008.
42. Nishikawa H, Wakano K, Kitani S. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell. Biochem Biophys Res Commun 362: 504-509, 2007.
43. 2+ signaling pathways in endothelial cells. J Cell Physiol. 220: 706-715, 2009.
44. Ou HC, Chou FP, Sheu WH, Hsu SL, Lee WJ. Protective effects of magnolol against oxidized LDL-mduced apoptosis in endothelial cells. Arch Toxicol. 8.1: 421-432, 2007.
45. Price LS, Langeslag M, Klooster JP, Hedrick PL, Juin K, Collard JG. Calcium signaling regulates translocation and activation of Rac. J Biol Chem 278: 39413-39421, 2003.
46. Reamers RA, Rice-Evans CA, Tyrrell RM, Clifford MN, Lean MEJ. Tea flavonoids and cardiovascular health. QJM 94: 277-282, 2001.
47. Romano MR, Logrono MD. Epigailocatechin-3-gallate relaxes the isolated bovine ophthalmic artery: involvement of phosphoinositide 3-kinaseAkt-nitric oxide/cGMP signalling pathway. Eur J Pharmacol. 608: 48-53, 2009.
48. Rueckschloss U, Duerrschmidt N, Morawietz H. NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid Redox Signal 5: 171-180, 2003.
49. Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction, of NAD(P)H oxidase by oxidized low-density lipoprotein in human, endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104: 1767-1772, 2001.
50. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77, 1997.
51. Tang F, Wu X, Wang T, Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H, Liu P. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol 46: 427-438, 2007.
52. Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol 84: 163-171, 2006.
53. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 1: 135-144, 2007.
54. Wever RMF, van Dam T, van Rijn HJM, de Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237: 340-344, 1997.
55. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 78: 2889-2897, 2006.
56. Xu H, Duan J, Wang W, Dai S, Wu Y, Sun R, Ren J. Reactive oxygen species mediate oxidized low-density lipoprotein-induced endothelin-1 gene expression via extracellular signal-regulated kinase in vascular endothelial cells. J Hypertens 26: 956-963, 2008.
57. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Antiangiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 24: 608-618, 2009.
58. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986, 1995.
59. Zheng Y, Lim EJ, Wang L, Smart EJ, Toborek M, Hennig B. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem 20: 202-209, 2009.